Health equity, care access and quality in headache - part 1

Nenhuma Miniatura disponível
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
TANA, Claudio
RAFFAELLI, Bianca
TORRE, Elena Ruiz de la
MASSI, Daniel Gams
KISANI, Najib
GARCIA-AZORIN, David
WALISZEWSKA-PROSOL, Marta
Citação
JOURNAL OF HEADACHE AND PAIN, v.25, n.1, article ID 12, 12p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Current definitions of migraine that are based mainly on clinical characteristics do not account for other patient's features such as those related to an impaired quality of life, due to loss of social life and productivity, and the differences related to the geographical distribution of the disease and cultural misconceptions which tend to underestimate migraine as a psychosocial rather than neurobiological disorder. Global differences definition, care access, and health equity for headache disorders, especially migraine are reported in this paper from a collaborative group of the editorial board members of the Journal of Headache and Pain. Other components that affect patients with migraine, in addition to the impact promoted by the migraine symptoms such as stigma and social determinants, are also reported.
Palavras-chave
Migraine, Health equity, Care access, Stigma, Clinical governance, COVID-19
URI
https://observatorio.fm.usp.br/handle/OPI/59190
Referências
  1. Acray-Zengb P, 2020, SANTE PUBLIQUE, V32, P419, DOI 10.3917/spub.204.0419
  2. Affaitati G, 2020, J NEURAL TRANSM, V127, P625, DOI 10.1007/s00702-019-02107-8
  3. Affatato O, 2021, J HEADACHE PAIN, V22, DOI 10.1186/s10194-021-01356-x
  4. [Anonymous], 2011, Atlas of Headache Disorders and Resources in the World
  5. Aparisi A, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19073961
  6. Ashina M, 2021, LANCET, V397, P1485, DOI 10.1016/S0140-6736(20)32160-7
  7. Atasoy HT, 2005, HEADACHE, V45, P25, DOI 10.1111/j.1526-4610.2005.05006.x
  8. Ayzenberg I, 2012, CEPHALALGIA, V32, P373, DOI 10.1177/0333102412438977
  9. Battista S, 2023, FRONT PSYCHOL, V14, DOI 10.3389/fpsyg.2023.1129926
  10. Befus DR, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0731-3
  11. Bicknell B, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24119577
  12. Blaszczyk B, 2023, J HEADACHE PAIN, V24, DOI 10.1186/s10194-023-01653-7
  13. Bonafede M, 2018, HEADACHE, V58, P700, DOI 10.1111/head.13275
  14. Brandt RB, 2022, CEPHALALGIA, V42, P1420, DOI 10.1177/03331024221113207
  15. Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062
  16. Burch R, 2018, HEADACHE, V58, P496, DOI 10.1111/head.13281
  17. Buse DC., 2016, Mayo Clin Proc, VS0025-6196, P00126
  18. Caronna E, 2020, CEPHALALGIA, V40, P1410, DOI 10.1177/0333102420965157
  19. Castaldo M, 2022, J HEADACHE PAIN, V23, DOI 10.1186/s10194-022-01400-4
  20. Chalmer MA, 2021, EUR J NEUROL, V28, P1726, DOI 10.1111/ene.14724
  21. Charleston L, 2021, J NATL MED ASSOC, V113, P223, DOI 10.1016/j.jnma.2020.09.148
  22. Charleston L, 2018, HEADACHE, V58, P506, DOI 10.1111/head.13286
  23. Chen SP, 2023, CEPHALALGIA, V43, DOI 10.1177/03331024231173354
  24. Cislaghi B, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010701
  25. Cottrell C, 2003, Headache: The Journal of Head and Face Pain, V43, DOI [10.1046/j.1526-4610.2003.03085_17.x, DOI 10.1046/J.1526-4610.2003.03085_17.X]
  26. Di Lauro M, 2023, NUTRIENTS, V15, DOI 10.3390/nu15204327
  27. Dodick DW, 2016, HEADACHE, V56, P821, DOI 10.1111/head.12774
  28. Dono F, 2021, NEUROL SCI, V42, P3965, DOI 10.1007/s10072-021-05444-3
  29. Ebbesen BD., 2023, J Pain, VS1526-5900, P00512
  30. Evlice A, 2023, CEPHALALGIA, V43, DOI 10.1177/03331024231194024
  31. FORSYTH PA, 1993, NEUROLOGY, V43, P1678, DOI 10.1212/WNL.43.9.1678
  32. García-Azorín D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59171-4
  33. Garcia-Azorin D., 2020, Neurologia (Engl Ed)
  34. García-Azorín D, 2023, CEPHALALGIA, V43, DOI 10.1177/03331024231212900
  35. Garcia-Azorin D, 2022, CEPHALALGIA, V42, P804, DOI 10.1177/03331024211068074
  36. García-Azorín D, 2021, J HEADACHE PAIN, V22, DOI 10.1186/s10194-021-01324-5
  37. García-Azorín D, 2022, ACTA NEUROL BELG, V122, P75, DOI 10.1007/s13760-021-01620-6
  38. Gong QY, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02216-6
  39. González-Celestino A, 2023, REV NEUROLOGIA, V77, P229, DOI 10.33588/rn.7710.2023063
  40. Gonzalez-Martinez A, 2022, J NEUROL, V269, P5702, DOI 10.1007/s00415-022-11225-5
  41. Grangeon L, 2023, J HEADACHE PAIN, V24, DOI 10.1186/s10194-023-01547-8
  42. Gross E, 2023, NEUROL THER, V12, P703, DOI 10.1007/s40120-023-00456-x
  43. Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
  44. Gürsoy BK, 2023, NEUROPSYCH DIS TREAT, V19, P63, DOI 10.2147/NDT.S398838
  45. Hamann T, 2023, PLOS ONE, V18, DOI 10.1371/journal.pone.0290318
  46. Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X
  47. Kempner J., 2014, Not tonight: migraine and the politics of gender and health, DOI [10.7208/chicago/9780226179292.001.0001, DOI 10.7208/CHICAGO/9780226179292.001.0001]
  48. Krymchantowski AV, 2022, ACTA NEUROL BELG, V122, P465, DOI 10.1007/s13760-021-01790-3
  49. Li YD, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00695-2
  50. Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954
  51. Linde M, 2012, EUR J NEUROL, V19, P703, DOI 10.1111/j.1468-1331.2011.03612.x
  52. Linde M, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0496-6
  53. Liu RZ, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-47
  54. Loder S, 2015, HEADACHE, V55, P214, DOI 10.1111/head.12506
  55. Manandhar K, 2015, J HEADACHE PAIN, V16, P1, DOI [10.1186/s10194-015-0580-y, 10.1186/s10194-016-0594-0]
  56. Mbewe E, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0515-7
  57. Meo SA, 2021, EUR REV MED PHARMACO, V25, P1663, DOI 10.26355/eurrev_202102_24877
  58. Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243
  59. Munblit D, 2022, LANCET RESP MED, V10, P632, DOI 10.1016/S2213-2600(22)00135-7
  60. Munoz-Ceron J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208728
  61. Navarro-Pérez MP, 2023, CEPHALALGIA, V43, DOI 10.1177/03331024231160743
  62. Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202
  63. Onofri A, 2023, J HEADACHE PAIN, V24, DOI 10.1186/s10194-023-01541-0
  64. Parikh SK, 2021, CURR PAIN HEADACHE R, V25, DOI 10.1007/s11916-021-00982-z
  65. Pearson C, 2019, J MED INTERNET RES, V21, DOI 10.2196/10479
  66. Perugino F, 2022, PAIN THER, V11, P1085, DOI 10.1007/s40122-022-00418-5
  67. Pescosolido BA, 2015, ANNU REV SOCIOL, V41, P87, DOI 10.1146/annurev-soc-071312-145702
  68. Polverino F, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.585866
  69. Raffaelli B, 2023, J HEADACHE PAIN, V24, DOI 10.1186/s10194-023-01699-7
  70. Raffaelli B, 2021, J MED INTERNET RES, V23, DOI 10.2196/32707
  71. Ravishankar K, 2003, CEPHALALGIA, V23, P577
  72. Rist PM, 2023, AM J MED, V136, P1094, DOI 10.1016/j.amjmed.2023.07.021
  73. Rodrigues AN, 2023, FRONT NEUROL, V14, DOI 10.3389/fneur.2023.1149294
  74. Rosendale N, 2022, NEUROL CLIN, V40, P231, DOI 10.1016/j.ncl.2021.08.012
  75. Rosignoli C, 2022, J HEADACHE PAIN, V23, DOI 10.1186/s10194-022-01471-3
  76. Ruffin J, 2010, AM J PUBLIC HEALTH, V100, pS8, DOI 10.2105/AJPH.2010.191957
  77. Rutberg S, 2012, DISABIL REHABIL, V34, P329, DOI 10.3109/09638288.2011.607211
  78. Saadi A, 2017, NEUROLOGY, V88, P2268, DOI [10.1212/WNL.0000000000004025, 10.1212/wnl.0000000000004025]
  79. Sakai F, 2023, CEPHALALGIA, V43, DOI 10.1177/03331024231165682
  80. Rocha PAS, 2020, HEADACHE, V60, P1797, DOI 10.1111/head.13941
  81. Saylor D, 2018, SEMIN NEUROL, V38, P182, DOI 10.1055/s-0038-1646946
  82. Schwedt TJ, 2009, HEADACHE, V49, P162, DOI 10.1111/j.1526-4610.2008.01323.x
  83. Sekiguchi K, 2022, CEPHALALGIA, V42, P266, DOI 10.1177/03331024211038654
  84. Silvestro M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10245914
  85. Smitherman TA, 2011, HEADACHE, V51, P923, DOI 10.1111/j.1526-4610.2011.01919.x
  86. Stein KS., 2023, Mayo Clin Proc
  87. Steiner TJ, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0970-7
  88. Stokes M, 2011, HEADACHE, V51, P1058, DOI 10.1111/j.1526-4610.2011.01945.x
  89. Stovner LJ, 2022, J HEADACHE PAIN, V23, DOI 10.1186/s10194-022-01402-2
  90. Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI [10.1016/S1474-4422(18)30322-3, 10.1016/S1474-4422(18)30387-9]
  91. Straburzynski M, 2023, NEUROL NEUROCHIR POL, V57, P43, DOI 10.5603/PJNNS.a2022.0049
  92. Straburzynski M, 2022, CEPHALALGIA, V42, P218, DOI 10.1177/03331024211040753
  93. Sukocheva OA, 2022, J ADV RES, V40, P179, DOI 10.1016/j.jare.2021.11.013
  94. SUWANWELA N, 1994, HEADACHE, V34, P435, DOI 10.1111/j.1526-4610.1994.hed3407435.x
  95. Suwanwela NC, 2022, J HEADACHE PAIN, V23, DOI 10.1186/s10194-022-01385-0
  96. Takizawa T, 2023, Expert Opin Drug Metab Toxicol, V5, P1
  97. Tana C, 2023, EXPERT OPIN EMERG DR, V28, P233, DOI 10.1080/14728214.2023.2288334
  98. Tana C, 2023, ANN MED, V55, DOI 10.1080/07853890.2023.2265298
  99. Tana C, 2023, CURR PHARM DESIGN, V29, P1964, DOI 10.2174/1381612829666230821092238
  100. Tana C, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24098304
  101. Tana C, 2023, CURR OPIN NEUROL, V36, P168, DOI 10.1097/WCO.0000000000001153
  102. Tana C, 2022, J HEADACHE PAIN, V23, DOI 10.1186/s10194-022-01450-8
  103. Ticinesi A, 2019, ADV EXP MED BIOL, V1178, P129, DOI 10.1007/978-3-030-25650-0_8
  104. Ticinesi A, 2019, EXERC IMMUNOL REV, V25, P8
  105. Ticinesi Andrea, 2018, Acta Biomed, V89, P52, DOI 10.23750/abm.v89i9-S.7906
  106. Ticinesi A, 2019, CURR OPIN CLIN NUTR, V22, P4, DOI 10.1097/MCO.0000000000000521
  107. Ticinesi A, 2018, CLIN INTERV AGING, V13, P1497, DOI 10.2147/CIA.S139163
  108. van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845
  109. Venkataramani V, 2022, NEW ENGL J MED, V387, P1813, DOI 10.1056/NEJMcibr2210069
  110. Vinyes D, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000029358
  111. Waliszewska-Prosól M, 2023, J HEADACHE PAIN, V24, DOI 10.1186/s10194-023-01575-4
  112. Waliszewska-Prosól M, 2021, J INFECT PUBLIC HEAL, V14, P903, DOI 10.1016/j.jiph.2021.04.013
  113. World Health Organization, 2021, COVID-19 and the social determinants of health and health equity: evidence brief [Internet]
  114. Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039
  115. Young WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054074
  116. Yu SY, 2012, HEADACHE, V52, P582, DOI 10.1111/j.1526-4610.2011.02061.x

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - COVID-19